|
|
|
Volumn 6, Issue 2 SUPPL. 1, 2000, Pages 34-39
|
|
From clinical trials to clinical practice: What we know and do not know about β-blockers and the heart
|
|
Author keywords
Asymptomatic heart failure; Barriers to treatment; Management issues; Severe heart failure
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUCINDOLOL;
METOPROLOL;
NORADRENALIN;
AGE;
ARTICLE;
CLINICAL PRACTICE;
DRUG EFFICACY;
ECONOMIC ASPECT;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART VENTRICLE REMODELING;
HUMAN;
PRIORITY JOURNAL;
RACE;
SEX;
ADRENERGIC BETA-ANTAGONISTS;
AGE FACTORS;
CHRONIC DISEASE;
CLINICAL TRIALS;
CONTINENTAL POPULATION GROUPS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HEART FAILURE, CONGESTIVE;
HUMANS;
PATIENT SELECTION;
SEVERITY OF ILLNESS INDEX;
SEX FACTORS;
|
|
EID: 0033921599
PISSN: 10719164
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (16)
|
